Medical conditions

‘Fewer patients than expected’ recruited in pilot of antidepressant new medicine service

Between December 2022 and September 2023, 193 patients used the pilot service, according to data presented by NHS England's pharmacy integration lead.…

Eating disorders: identification, treatment and support

Pharmacists are well positioned to identify the signs and symptoms of an eating disorder and can provide access to sources of help and support.…

‘Artificial pancreas’ offers better glycaemic control than standard therapy for pregnant women with type 1 diabetes, study reveals

Pregnant women treated with hybrid closed-loop therapy for type 1 diabetes mellitus spent less time at hyperglycaemic state, gained less maternal weight and had fewer hypertensive complications.…

Pharmacists have a vital role in shining a brighter light on blood cancer

More than three quarters of patients with blood cancer consider their illness to be a “hidden cancer” because of a lack of public understanding — pharmacists can help to change that.…

Exploring the safe and effective tapering solutions in the NHS

There has been a growing consensus that the safest approach to discontinuing psychiatric medicines is through a gradual and hyperbolic tapering process. This concept is thoroughly explained in the informative article authored by Mark Horowitz and David Taylor entitled 'Case-based learning: safe with…

How to develop a new clinical service

Delivery of the ‘NHS long-term plan’ requires the development of innovative new services. This article outlines how a new clinical service can be developed sharing learnings from the development of a paediatric ambulatory care service.…

Scottish government considers nicotine addiction treatment for children aged under 12 years

Experts say that teachers and parents are raising concerns about nicotine addiction in children aged under 12 years.…

Burnout among pharmacy professionals needs to be addressed at ‘systemic level’, RPS report finds

The report stated that individuals should seek to prioritise their wellbeing, but highlighted that many factors affecting staff wellbeing have been created by the healthcare system.…

An audit of pharmacological therapy on discharge for patients admitted with acute decompensated HFrEF

Pharmacological management of acute decompensated heart failure with reduced ejection fraction (HFrEF) reduces mortality and morbidity[1]. International and local guidelines recommend with class I evidence for the use of renin-angiotensin system inhibitor (RAASi), beta-blocker, miner…

Colchicine for cardiovascular disease: is UK clinical practice missing out?

A deep dive into whether colchicine, an ancient treatment for inflammation, has a future in cardiovascular disease therapy in the UK.…